Pharmaceutical News

RSS

New polymer effectively captures nicotine molecules and analogues

Newly synthesized polymer, fitted with molecular pincers of carefully tailored structure, effectively captures nicotine molecules and its analogues.

5 Aug 2011

Study stresses importance of broad-spectrum sunscreen to help prevent skin cancer

With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.

5 Aug 2011

Health Affairs report describes ground-breaking effort that aims to prevent opioid abuse

Fatal overdoses involving prescribed opioids tripled in the United States between 1999 and 2006, climbing to almost 14,000 deaths annually-more than cocaine and heroin overdoses combined. Hospitalizations and emergency room visits related to prescription opioid pain medicines such as oxycodone and hydrocodone also increased dramatically in the same period.

5 Aug 2011

Levels of body chemical PCT influence duration of antibiotic use

Measuring the levels of a natural body chemical may allow doctors to reduce the duration of antibiotic use and improve the health outcomes of critically ill patients.

5 Aug 2011

PharmOut creates online database of Good Manufacturing Practice guidelines

For manufacturers who must comply with current Good Manufacturing Practice (GMP), keeping track of the latest guidelines can be time consuming and difficult. This task is considerably more complex if the manufacturer exports to multiple countries, each with their own GMP requirements.

5 Aug 2011

FDA approves first scorpion antivenom

The U.S. Food and Drug Administration today approved Anascorp-, an antivenom produced in Mexico and tested in clinical trials conducted through the University of Arizona, for use in treating patients suffering the effects of scorpion sting.

5 Aug 2011

Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, today announced that it has submitted an Abbreviated New Drug Application (ANDA) for chewable metformin with the U.S. Food and Drug Administration.

4 Aug 2011

Scientists say antibiotic-resistant salmonella strain may spread worldwide

"Scientists have identified an emerging 'superbug' strain of salmonella that is highly resistant to the antibiotic Ciprofloxacin, or Cipro, often used for severe salmonella infections, and say they fear it may spread around the world," according to a study published online Tuesday in the Journal of Infectious Diseases, Reuters reports.

4 Aug 2011

U.S. PTO to reissue two patents for Dey Pharma's Perforomist Inhalation Solution

Dey Pharma L.P., a subsidiary of Mylan Inc., today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals.

4 Aug 2011

SynCo Bio commences release of drug products after expansion of Class A zone

SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of its Class A zone.

4 Aug 2011

New research highlights urgent need to develop specific guidelines for HIV-infected children

Children with HIV have persistently high levels of cholesterol and other lipids during treatment with antiretroviral medications, according to a pair of studies in JAIDS: Journal of Acquired Immune Deficiency Syndromes.

4 Aug 2011

Avaxia receives BARDA contract to develop new radiation mitigation drug

Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.

4 Aug 2011

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

NanoBio Corporation today announced a licensing agreement with the National Institutes of Health (NIH) that represents a significant step forward in developing the first vaccine to protect against respiratory syncytial virus (RSV) infections.

4 Aug 2011

ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a patent in France and the United Kingdom relating to the treatment and detection of multiple myeloma and ovarian cancer.

4 Aug 2011

ICORE Healthcare receives URAC Accreditation for Specialty Pharmacy

Magellan Health Services Inc. has announced that ICORE Healthcare, its Specialty Pharmaceutical division, has been awarded the Specialty Pharmacy Accreditation from URAC, a Washington, D.C. based health care accrediting organization that establishes quality standards for the health care industry.

4 Aug 2011

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

The U.S. Food and Drug Administration today approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

4 Aug 2011

Incyte announces FDA acceptance of NDA filing for ruxolitinib to treat myelofibrosis

Incyte Corporation announced today that the US Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Incyte's lead investigational compound, ruxolitinib, as a potential treatment for patients with myelofibrosis.

3 Aug 2011

Researchers discover biological mechanism behind sarcopenia

Researchers at Columbia University Medical Center have discovered the biological mechanism behind age-related loss of muscle strength and identified a drug that may help reverse this process.

3 Aug 2011

Biomoda to receive European patent for porphyrin-based compound to detect cancer

Cancer diagnostics company Biomoda, Inc. received notification from the European Patent Office of its intention to grant the company's patent application related to a method of using Biomoda's proprietary porphyrin-based compound to detect cancer and pre-cancerous cells in body fluid and tissue samples.

3 Aug 2011

Biotica acquires full rights to rapamycin analogue program from Pfizer

Biotica Technology Ltd. today announced that it has regained full rights from Pfizer Inc. to its rapamycin analogue program, including transfer of data and materials.

3 Aug 2011

Pharmaceutical News

New polymer effectively captures nicotine molecules and analogues

Study stresses importance of broad-spectrum sunscreen to help prevent skin cancer

Health Affairs report describes ground-breaking effort that aims to prevent opioid abuse

Levels of body chemical PCT influence duration of antibiotic use

PharmOut creates online database of Good Manufacturing Practice guidelines

FDA approves first scorpion antivenom

Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes

Scientists say antibiotic-resistant salmonella strain may spread worldwide

U.S. PTO to reissue two patents for Dey Pharma's Perforomist Inhalation Solution

SynCo Bio commences release of drug products after expansion of Class A zone

New research highlights urgent need to develop specific guidelines for HIV-infected children

Avaxia receives BARDA contract to develop new radiation mitigation drug

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

ICORE Healthcare receives URAC Accreditation for Specialty Pharmacy

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

Incyte announces FDA acceptance of NDA filing for ruxolitinib to treat myelofibrosis

Researchers discover biological mechanism behind sarcopenia

Biomoda to receive European patent for porphyrin-based compound to detect cancer

Biotica acquires full rights to rapamycin analogue program from Pfizer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News